<DOC>
	<DOCNO>NCT00857116</DOCNO>
	<brief_summary>The purpose study investigate whether treatment intestinal helminth patient pulmonary tuberculosis undergo chemotherapy could improve clinical outcome enhance host immunity .</brief_summary>
	<brief_title>Deworming Against Tuberculosis</brief_title>
	<detailed_description>Mycobacterium tuberculosis cause tuberculosis ( TB ) major global public health problem . Because increase multi drug resistance long treatment period least six month , new therapeutic option urgently need . In country like Ethiopia TB endemic , chronic worm infection also highly prevalent . Recent data support helminth infection might limit host response TB inhibition TH1-response crucial control disease . In study want test hypothesis Albendazole treatment patient coinfected helminth TB could improve clinical outcome addition chemotherapy TB . Additionally investigate immunological interaction TB chronic helminth infection .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>Informed write consent take part study Newly diagnose pulmonary TB patient accord WHO definition active tuberculosis positive stool sample helminth Schistosoma spp . Pregnancy Corticosteroid antibiotic treatment Symptomatic ( diarrhoea ) infection cause worm infection Chronic diseases acute infectious disease TB HIV Stool sample positive Schistosoma spp</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Deworming</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>TB-score</keyword>
	<keyword>Albendazole</keyword>
	<keyword>Helminths</keyword>
</DOC>